{"transactions":[{"id":686298,"issuer":{"id":7495,"kind":"organization","name":"CEL SCI CORP"},"owners":[{"id":23142,"kind":"person","name":"Watson Robert Eugene","position":1,"cik":"0001511858","reported_name":"Watson Robert Eugene","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options","published_at":"2026-08-17T13:43:35.000Z","date":"2026-08-14","kind":"grant","planned":false,"acquired":true,"shares":110000,"price":0.01,"value":1100.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options vest in three (3) equal annual installments commencing one year after the grant date."}],"balance_after":137271,"derivative":{"exercise_price":1.49,"expiration_date":"2036-08-13","underlying":"Common Stock","underlying_shares":110000},"source":{"system":"sec-edgar","filing":"0001511858-26-000001","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/725363/000151185826000001/primary_doc.xml","form_type":"4"}},{"id":1080394,"issuer":{"id":7495,"kind":"organization","name":"CEL SCI CORP"},"owners":[{"id":23142,"kind":"person","name":"Watson Robert Eugene","position":1,"cik":"0001511858","reported_name":"Watson Robert Eugene","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options","published_at":"2025-07-29T21:20:52.000Z","date":"2025-07-28","kind":"grant","planned":false,"acquired":true,"shares":4000,"price":0.01,"value":40.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options vest in three (3) equal annual installments commencing one year after the grant date."}],"balance_after":27266,"derivative":{"exercise_price":8.2,"expiration_date":"2035-07-27","underlying":"Common Stock","underlying_shares":4000},"source":{"system":"sec-edgar","filing":"0001236030-25-000014","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/725363/000123603025000014/primary_doc.xml","form_type":"4"}},{"id":1080388,"issuer":{"id":7495,"kind":"organization","name":"CEL SCI CORP"},"owners":[{"id":23142,"kind":"person","name":"Watson Robert Eugene","position":1,"cik":"0001511858","reported_name":"Watson Robert Eugene","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-07-29T11:56:00.000Z","date":"2025-07-25","kind":"purchase","planned":false,"acquired":true,"shares":2919,"price":6.85,"value":19995.15,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On July 25, 2025, Mr. Watson purchased 2,919 shares of restricted stock directly from the Company at the closing price on July 24, 2025, the most recent closing price available."}],"balance_after":3733,"source":{"system":"sec-edgar","filing":"0001236030-25-000008","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/725363/000123603025000008/primary_doc.xml","form_type":"4"}},{"id":1521551,"issuer":{"id":7495,"kind":"organization","name":"CEL SCI CORP"},"owners":[{"id":23142,"kind":"person","name":"Watson Robert Eugene","position":1,"cik":"0001511858","reported_name":"Watson Robert Eugene","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-10T13:04:18.000Z","date":"2024-05-08","kind":"purchase","planned":false,"acquired":true,"shares":20000,"price":1.39,"value":27800.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On May 8, 2024, Mr. Watson purchased 20,000 shares of restricted stock directly from the Company at the closing price on May 8, 2024, the most recent closing price available."}],"balance_after":24431,"source":{"system":"sec-edgar","filing":"0001236030-24-000015","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/725363/000123603024000015/primary_doc.xml","form_type":"4"}},{"id":1537249,"issuer":{"id":7495,"kind":"organization","name":"CEL SCI CORP"},"owners":[{"id":23142,"kind":"person","name":"Watson Robert Eugene","position":1,"cik":"0001511858","reported_name":"Watson Robert Eugene","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options","published_at":"2024-04-23T21:23:37.000Z","date":"2024-04-19","kind":"grant","planned":false,"acquired":true,"shares":64000,"price":0.01,"value":640.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options vest in three (3) equal annual installments commencing one year after the grant date."}],"balance_after":698000,"derivative":{"exercise_price":1.5,"expiration_date":"2034-04-18","underlying":"Common Stock","underlying_shares":64000},"source":{"system":"sec-edgar","filing":"0001236030-24-000011","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/725363/000123603024000011/primary_doc.xml","form_type":"4"}},{"id":1811415,"issuer":{"id":7495,"kind":"organization","name":"CEL SCI CORP"},"owners":[{"id":23142,"kind":"person","name":"Watson Robert Eugene","position":1,"cik":"0001511858","reported_name":"Watson Robert Eugene","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options","published_at":"2023-08-10T20:50:02.000Z","date":"2023-08-08","kind":"grant","planned":false,"acquired":true,"shares":64000,"price":0.01,"value":640.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options vest in three (3) equal annual installments commencing one year after the grant date."}],"balance_after":634000,"derivative":{"exercise_price":1.36,"expiration_date":"2033-08-07","underlying":"Common Stock","underlying_shares":64000},"source":{"system":"sec-edgar","filing":"0001236030-23-000013","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/725363/000123603023000013/primary_doc.xml","form_type":"4"}},{"id":2233502,"issuer":{"id":7495,"kind":"organization","name":"CEL SCI CORP"},"owners":[{"id":23142,"kind":"person","name":"Watson Robert Eugene","position":1,"cik":"0001511858","reported_name":"Watson Robert Eugene","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options","published_at":"2022-06-14T21:30:44.000Z","date":"2022-06-13","kind":"grant","acquired":true,"shares":64000,"price":0.01,"value":640.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options vest in three (3) equal annual installments commencing one year after the grant date."}],"balance_after":570000,"derivative":{"exercise_price":3.35,"expiration_date":"2032-06-12","underlying":"Common Stock","underlying_shares":64000},"source":{"system":"sec-edgar","filing":"0001236030-22-000016","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/725363/000123603022000016/primary_doc.xml","form_type":"4"}},{"id":2640220,"issuer":{"id":7495,"kind":"organization","name":"CEL SCI CORP"},"owners":[{"id":23142,"kind":"person","name":"Watson Robert Eugene","position":1,"cik":"0001511858","reported_name":"Watson Robert Eugene","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-07-07T14:51:27.000Z","date":"2021-07-06","kind":"purchase","acquired":true,"shares":1250,"price":8,"value":10000.0,"ownership":{"direct":true},"balance_after":4431,"source":{"system":"sec-edgar","filing":"0001646989-21-000008","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/725363/000164698921000008/primary_doc.xml","form_type":"4"}},{"id":2711564,"issuer":{"id":7495,"kind":"organization","name":"CEL SCI CORP"},"owners":[{"id":23142,"kind":"person","name":"Watson Robert Eugene","position":1,"cik":"0001511858","reported_name":"Watson Robert Eugene","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options","published_at":"2021-05-17T21:34:55.000Z","date":"2021-05-14","kind":"grant","acquired":true,"shares":128000,"price":0.01,"value":1280.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each option entitles the holder to purchase one share of the Company's common stock at a price of $20.61 per share. The stock options vest 100% upon either (a) the filing of the first marketing application for any pharmaceutical based upon the Company's Multikine technology in any of the USA, Canada, UK, Germany, France, Italy, Spain, Japan, or Australia, or (b) if the closing price of the Company's common stock exceeds $42.00 for one trading day.  None of the options will be exercisable before May 13, 2022."}],"balance_after":506000,"derivative":{"exercise_price":20.61,"expiration_date":"2031-05-13","underlying":"Common Stock","underlying_shares":128000},"source":{"system":"sec-edgar","filing":"0001236215-21-000010","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/725363/000123621521000010/primary_doc.xml","form_type":"4"}},{"id":2976665,"issuer":{"id":7495,"kind":"organization","name":"CEL SCI CORP"},"owners":[{"id":23142,"kind":"person","name":"Watson Robert Eugene","position":1,"cik":"0001511858","reported_name":"Watson Robert Eugene","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-11-18T14:59:17.000Z","date":"2020-11-18","kind":"purchase","acquired":true,"shares":800,"price":11.77,"value":9416.0,"ownership":{"direct":true},"balance_after":3181,"source":{"system":"sec-edgar","filing":"0001236031-20-000034","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/725363/000123603120000034/primary_doc.xml","form_type":"4"}},{"id":3173554,"issuer":{"id":7495,"kind":"organization","name":"CEL SCI CORP"},"owners":[{"id":23142,"kind":"person","name":"Watson Robert Eugene","position":1,"cik":"0001511858","reported_name":"Watson Robert Eugene","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options","published_at":"2020-04-20T21:05:28.000Z","date":"2020-04-20","kind":"grant","acquired":true,"shares":128000,"price":0.01,"value":1280.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These stock options are performance based. Each option entitles the holder to purchase one share of the Company's common stock at a price of $10.93 per share. The stock options vest upon the achievement of the following performance goals:  i) 25% of the options will vest when the closing price of the Company's common stock exceeds $20.00 for ten consecutive trading days; ii) 50% of the options will vest when the closing price of the Company's common stock exceeds $25.00 for ten consecutive trading days; iii) 75% of the options will vest when the closing price of the Company's common stock exceeds $30.00 for ten consecutive trading days; and iv)  100% of the options will vest when either (a) the filing of the first marketing application for any pharmaceutical based upon the Company's Multikine technology in any of the USA, Canada, UK, Germany, France, Italy, Spain, Japan, or Australia or (b) the closing price of the Company's common stock exceeds $40.00 for ten consecutive trading days."}],"balance_after":378000,"derivative":{"exercise_price":10.93,"expiration_date":"2030-04-19","underlying":"Common Stock","underlying_shares":128000},"source":{"system":"sec-edgar","filing":"0001236031-20-000023","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/725363/000123603120000023/primary_doc.xml","form_type":"4"}},{"id":3245224,"issuer":{"id":7495,"kind":"organization","name":"CEL SCI CORP"},"owners":[{"id":23142,"kind":"person","name":"Watson Robert Eugene","position":1,"cik":"0001511858","reported_name":"Watson Robert Eugene","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-02-27T12:57:25.000Z","date":"2020-02-26","kind":"purchase","acquired":true,"shares":923,"price":10.83,"value":9996.09,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On February 26, 2020, Mr. Watson purchased $10,000 worth of restricted stock directly from the Company at the closing price on February 26, 2020, the most recent closing price available."}],"balance_after":2381,"source":{"system":"sec-edgar","filing":"0001236031-20-000011","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/725363/000123603120000011/primary_doc.xml","form_type":"4"}},{"id":3535958,"issuer":{"id":7495,"kind":"organization","name":"CEL SCI CORP"},"owners":[{"id":23142,"kind":"person","name":"Watson Robert Eugene","position":1,"cik":"0001511858","reported_name":"Watson Robert Eugene","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-08T12:12:13.000Z","date":"2019-05-07","kind":"grant","acquired":true,"shares":1458,"price":6.86,"value":10001.88,"ownership":{"direct":true},"balance_after":1458,"source":{"system":"sec-edgar","filing":"0001236031-19-000019","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/725363/000123603119000019/primary_doc.xml","form_type":"4"}},{"id":3557221,"issuer":{"id":7495,"kind":"organization","name":"CEL SCI CORP"},"owners":[{"id":23142,"kind":"person","name":"Watson Robert Eugene","position":1,"cik":"0001511858","reported_name":"Watson Robert Eugene","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options","published_at":"2019-04-12T21:03:24.000Z","date":"2019-04-11","kind":"grant","acquired":true,"shares":160000,"price":0.01,"value":1600.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options vest in three (3) equal annual installments commencing one year after the grant date."}],"balance_after":250000,"derivative":{"exercise_price":5.65,"expiration_date":"2029-04-10","underlying":"Common Stock","underlying_shares":160000},"source":{"system":"sec-edgar","filing":"0001236031-19-000014","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/725363/000123603119000014/primary_doc.xml","form_type":"4"}},{"id":3949052,"issuer":{"id":7495,"kind":"organization","name":"CEL SCI CORP"},"owners":[{"id":23142,"kind":"person","name":"Watson Robert Eugene","position":1,"cik":"0001511858","reported_name":"Watson Robert Eugene","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options","published_at":"2018-05-03T20:59:31.000Z","date":"2018-05-01","kind":"grant","acquired":true,"shares":80000,"price":0.01,"value":800.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options vest in three (3) equal annual installments commencing one year after the grant date."}],"balance_after":90000,"derivative":{"exercise_price":2.45,"expiration_date":"2028-04-30","underlying":"Common Stock","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0001236031-18-000023","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/725363/000123603118000023/primary_doc.xml","form_type":"4"}},{"id":4099995,"issuer":{"id":7495,"kind":"organization","name":"CEL SCI CORP"},"owners":[{"id":23142,"kind":"person","name":"Watson Robert Eugene","position":1,"cik":"0001511858","reported_name":"Watson Robert Eugene","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options","published_at":"2018-01-16T21:28:01.000Z","date":"2017-12-18","kind":"grant","acquired":true,"shares":10000,"price":0.01,"value":100.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options vest in three (3) equal annual installments commencing one year after the grant date."}],"balance_after":10000,"derivative":{"exercise_price":1.84,"expiration_date":"2027-12-17","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001236031-18-000006","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/725363/000123603118000006/primary_doc.xml","form_type":"4"}}]}